FDA opens new path for Alzheimer’s therapy as failures mount
The Food and Drug Administration proposal will create new opportunities for drugmakers after repeated failures from companies including Indianapolis-based Eli Lilly and Co.
Diseases
Articles
House panel approves bill to raise state smoking age from 18 to 21
Lawmakers stripped a provision from the bill that would have boosted the cigarette tax from 99 cents a pack to $2.99.
IU Health expands specialty cancer program into new facility
The program is for patients with Stage 3 or Stage 4 cancer who had not had success with traditional treatments. Under the program, scientists analyze patients’ genome, leading to a personalized treatment plan.
Blood test to detect 8 cancers early gives promising results
Scientists are reporting progress on a blood test to detect many types of cancer at an early stage, including some of the most deadly ones that lack screening tools.
Bathroom bill would allow customers access to employee restrooms
A state Senate committee approved legislation Monday that would require businesses to allow customers with medical conditions to access employee restrooms if a public restroom is not available.
Lawsuit accuses Lilly of using kickbacks to boost insulin sales
A recently unsealed suit accuses the Indianapolis-based drugmaker of offering free nursing services to doctors to induce them to prescribe the company’s products.
Food insecurity, hunger vex large swath of Indianapolis residents
Nearly 175,000 food-insecure people live in the city. About 47,000 of them are children, whose ability to learn and thrive can be hampered, according to panelists at a local hunger summit on Friday.
IU med school wins $7.6M grant to study Alzheimer’s disease
The study will focus on early-onset Alzheimer’s disease, which are about 5 percent of patients.
Struggling Endocyte spending millions for rights to prostate-cancer drug
After struggling for more than 20 years to develop cancer drugs without success, West Lafayette-based Endocyte Inc. is pausing it own R&D efforts to concentrate on a potential blockbuster drug from a German chemical company.
Wanted: 1 million people to study genes, habits, health
In a quest to end cookie-cutter health care, U.S. researchers are getting ready to recruit more than 1 million people for an unprecedented study to learn how our genes, environments and lifestyles interact—and to finally customize ways to prevent and treat disease. Why does one sibling get sick but not another? Why does a drug […]
IU, Purdue get $2.55M to study breast cancer
Researchers at Indiana University and Purdue University have received $2.55 million from Susan G. Komen to study possible new treatments.
Lilly breast cancer drug results could challenge Pfizer pill
li Lilly and Co.’s experimental breast cancer drug abemaciclib, when combined with standard therapy, slowed the progression of tumors in patients with an advanced form of the disease.
Indiana gets record $26 million to expand HIV treatment
The money will be used to increase treatment capacity for patients by funding psychiatric nurse practitioners and mental health and addiction counselors.
Lilly, other drug giants hunt for patients in India’s remote corners
Global pharmaceutical companies including Indianapolis-based Eli Lilly and Co. are heading into smaller cities and rural areas to learn about the health care needs of about 70 percent of India’s population.
Lilly diabetes drug Jardiance falls short of quarterly sales predictions
Shares in Eli Lilly and Co. stock fell more than 3 percent Tuesday after the Indianapolis-based drugmaker released a quarterly earnings report that showed sales of potential blockbuster drug Jardiance missed expectations by a wide margin.
Community makes latest push into oncology with $60M cancer center
Community Health Network’s new Cancer Center North, which will have its grand opening Saturday is designed to lift patients’ spirits as much as kill cancer cells.
Local Roche units sue pharmacies over alleged test-strip scheme
Two Indianapolis-based subsidiaries of Swiss pharmaceutical giant Roche Group are accusing a group of pharmacies and supply houses of engaging in an elaborate scheme to defraud Roche of millions of dollars worth of sales on diabetes test strips.
Cancer often comes down to random chance, study says
Lifestyle and heredity get the most blame for cancer, but new research suggests random chance plays a bigger role than people realize.
Eli Lilly chasing psoriasis jackpot with Taltz
Taltz, which hit the market last year, is taking on an armful of older treatments, including creams, lotions, pills and injectables, such as Amgen’s Enbrel and AbbVie’s Humira.
Chinese firm working with Lilly gets positive results on cancer drug
Hutchison China MediTech Ltd., the biotechnology company that has a partnership with Eli Lilly and Co., on Friday reported positive late-stage results for its drug to treat colorectal cancer.